In brown adipocytes, adrenergically induced β1-/β3-(Gs)-, α2-(Gi)- and α1-(Gq)-signalling to Erk1/2 activation is not mediated via EGF receptor transactivation

Experimental Cell Research

Volumn 319, Issue 17, 2013, Pages 2718-2727

  Wang, Yanling ^a   Fälting, Johanna M ^a   Mattsson, Charlotte L ^a   Holmström, Therése E ^a   Nedergaard, Jan ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Brown adipocytes; Erk1 2 activation; G protein coupled receptors; Norepinephrine; Transactivation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CIRAZOLINE; CLONIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORADRENALIN;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL CYCLE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 84885336217     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.007     Document Type: Article

References (57)

1. Nedergaard J., Bengtsson T., Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Cell Physiol. 2007, 293:E444-E452.
2. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., Kolodny G.M., Kahn C.R. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
3. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-Kobayashi J., Iwanaga T., Miyagawa M., Kameya T., Nakada K., Kawai Y., Tsujisaki M. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
4. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
5. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N.J., Enerbäck S., Nuutila P. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 2009, 360:1518-1525.
6. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., Nedergaard J., Cinti S. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J. 2009, 23:3113-3120.
7. Géloën A., Collet A.J., Guay G., Bukowiecki L.J. β-Adrenergic stimulation of brown adipocyte proliferation. Am. J. Physiol. Cell Physiol. 1988, 254:C175-C182.
8. Rehnmark S., Nedergaard J. DNA synthesis in mouse brown adipose tissue is under beta-adrenergic control. Exp. Cell Res 1989, 180:574-579.
9. Bronnikov G., Houstek J., Nedergaard J. Beta-adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. Mediation via beta 1 but not via beta 3 adrenoceptors. J. Biol. Chem 1992, 267:2006-2013.
10. Briscini L., Tonello C., Dioni L., Carruba M., Nisoli E. Bcl-2 and Bax are involved in the sympathetic protection of brown adipocytes from obesity-linked apoptosis. FEBS Lett 1998, 431:80-84.
11. Lindquist J.M., Rehnmark S. Ambient temperature regulation of apoptosis in brown adipose tissue: Erk 1/2 promotes norepinephrine-dependent cell survival. J. Biol. Chem 1998, 273:30147-30156.
12. Cannon B., Nedergaard J. Adrenergic regulation of brown adipocyte differentiation. Biochem. Soc. Trans. 1996, 24:407-412.
13. Nedergaard J., Cannon B., Lindberg O. Microcalorimetry of isolated mammalian cells. Nature (London) 1977, 267:518-520.
14. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
15. Rozengurt E. Early signals in the mitogenic response. Science 1986, 234:161-166.
16. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379:557-560.
17. Daub H., Wallasch C., Lankenau A., Herrlich A., Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 1997, 16:7032-7044.
18. Zwick E., Daub H., Aoki N., Yamaguchi-Aoki Y., Tinhofer I., Maly K., Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J. Biol. Chem. 1997, 272:24767-24770.
19. Della Rocca G.J., Maudsley S., Daaka Y., Lefkowitz R.J., Luttrell L.M. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J. Biol. Chem 1999, 274:13978-13984.
20. Rozengurt E., Walsh J.H. Gastrin CCK, signaling, and cancer. Annu. Rev. Physiol. 2001, 63:49-76.
21. Li B., Du T., Li H., Gu L., Zhang H., Huang J., Hertz L., Peng L. Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons. Br. J. Pharmacol. 2008, 154:191-203.
22. Du T., Li B., Liu S., Zang P., Prevot V., Hertz L., Peng L. ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors. Neurochem. Int. 2009, 55:593-600.
23. Du T., Li B., Li H., Li M., Hertz L., Peng L. Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent. J. Neurochem. 2010, 115:1007-1023.
24. Nagareddy P.R., MacLeod K.M., McNeill J.H. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats. Cardiovasc. Res. 2010, 87:177-186.
25. Oganesian A., Yarov-Yarovoy V., Parks W.C., Schwinn D.A. Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway. Proc. Nat. Acad. Sci. U.S.A. 2011, 108:19796-19801.
26. Chen H., Ma N., Xia J., Liu J., Xu Z. beta2-Adrenergic receptor-induced transactivation of epidermal growth factor receptor and platelet-derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival. Cell Biol. Int. 2012, 36:237-244.
27. Liebmann C. EGF receptor activation by GPCRs: an universal pathway reveals different versions. Mol. Cell. Endocrinol 2011, 331:222-231.
28. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell Physiol 2007, 213:589-602.
29. Carpenter G. The EGF receptor: a nexus for trafficking and signaling. Bioessays 2000, 22:697-707.
30. Drube S., Stirnweiss J., Valkova C., Liebmann C. Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell. Signalling 2006, 18:1633-1646.
31. Holmstrom T.E., Mattsson C.L., Falting J.M., Nedergaard J. Differential signalling pathways for EGF versus PDGF activation of Erk1/2 MAP kinase and cell proliferation in brown pre-adipocytes. Exp. Cell Res 2008, 314:3581-3592.
32. Holmstrom T.E., Mattsson C.L., Wang Y., Iakovleva I., Petrovic N., Nedergaard J. Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes. Exp. Cell Res. 2010, 316:2664-2675.
33. Gschwind A., Prenzel N., Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 2002, 62:6329-6336.
34. Nechad M., Kuusela P., Carneheim C., Bjorntorp P., Nedergaard J., Cannon B. Development of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp. Cell Res. 1983, 149:105-118.
35. Arteaga C.L., Ramsey T.T., Shawver L.K., Guyer C.A. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. J. Biol. Chem. 1997, 272:23247-23254.
36. Mattsson C.L., Andersson E.R., Nedergaard J. Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling. Biochim. Biophys. Acta 2010, 1803:983-989.
37. Rehnmark S., Nechad M., Herron D., Cannon B., Nedergaard J. Alpha- and beta-adrenergic induction of the expression of the uncoupling protein thermogenin in brown adipocytes differentiated in culture. J. Biol. Chem 1990, 265:16464-16471.
38. Bronnikov G.E., Zhang S.J., Cannon B., Nedergaard J. A dual component analysis explains the distinctive kinetics of cAMP accumulation in brown adipocytes. J. Biol. Chem. 1999, 274:37770-37780.
39. Bengtsson T., Cannon B., Nedergaard J. Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes. Biochem. J. 2000, 347(3):643-651.
40. i-mediated in Brown adipocytes. J. Biol. Chem. 2000, 275:22670-22677.
41. Bronnikov G., Bengtsson T., Kramarova L., Golozoubova V., Cannon B., Nedergaard J. Beta1 to beta3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct beta-adrenoceptor subtype mediation of proliferation and differentiation. Endocrinology 1999, 140:4185-4197.
42. Himms-Hagen J., Cui J., Danforth E., Taatjes D.J., Lang S.S., Waters B.L., Claus T.H. Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am. J. Physiol. Cell Physiol. 1994, 266:R1371-R1382.
43. Shah B.H., Shah F.B., Catt K.J. Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons. J. Neurochem. 2006, 96:520-532.
44. Chen L., Hodges R.R., Funaki C., Zoukhri D., Gaivin R.J., Perez D.M., Dartt D.A. Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells. Am. J. Physiol. Cell Physiol. 2006, 291:C946-C956.
45. Nagareddy P.R., Chow F.L., Hao L., Wang X., Nishimura T., MacLeod K.M., McNeill J.H., Fernandez-Patron C. Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis. Cardiovasc. Res. 2009, 84:368-377.
46. Karkoulias G., Mastrogianni O., Lymperopoulos A., Paris H., Flordellis C. alpha(2)-Adrenergic receptors activate MAPK and Akt through a pathway involving arachidonic acid metabolism by cytochrome P450-dependent epoxygenase, matrix metalloproteinase activation and subtype-specific transactivation of EGFR. Cell. Signalling 2006, 18:729-739.
47. Buffin-Meyer B., Crassous P.A., Delage C., Denis C., Schaak S., Paris H. EGF receptor transactivation and PI3-kinase mediate stimulation of ERK by alpha(2A)-adrenoreceptor in intestinal epithelial cells: a role in wound healing. Eur. J. Pharmacol 2007, 574:85-93.
48. Noma T., Lemaire A., Naga Prasad S.V., Barki-Harrington L., Tilley D.G., Chen J., Le Corvoisier P., Violin J.D., Wei H., Lefkowitz R.J., Rockman H.A. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J. Clin. Invest. 2007, 117:2445-2458.
49. Tilley D.G., Kim I.M., Patel P.A., Violin J.D., Rockman H.A. Beta-arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J. Biol. Chem. 2009, 284:20375-20386.
50. Zheng J., Shen H., Xiong Y., Yang X., He J. The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas. Amino Acids 2010, 38:75-84.
51. 2-adrenergic receptor. Proc. Nat. Acad. Sci. U.S.A. 1993, 90:3665-3669.
52. Jockers R., Da Silva A., Strosberg A.D., Bouvier M., Marullo S. New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors. J. Biol. Chem 1996, 271:9355-9362.
53. Evans B.A., Papaioannou M., Hamilton S., Summers R.J. Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues. Br. J. Pharmacol 1999, 127:1525-1531.
54. Hutchinson D.S., Bengtsson T., Evans B.A., Summers R.J. Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br. J. Pharmacol. 2002, 135:1903-1914.
55. Robidoux J., Kumar N., Daniel K.W., Moukdar F., Cyr M., Medvedev A.V., Collins S. Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation. J. Biol. Chem. 2006, 281:37794-37802.
56. Barbier A.J., Poppleton H.M., Yigzaw Y., Mullenix J.B., Wiepz G.J., Bertics P.J., Patel T.B. Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J. Biol. Chem. 1999, 274:14067-14073.
57. Lee P., Swarbrick M.M., Zhao J.T., Ho K.K. Inducible brown adipogenesis of supraclavicular fat in adult humans. Endocrinology 2011, 152:3597-3602.